What's breaking now, across thousands of outlets.
Novo Nordisk has a huge opportunity in GLP-1 weight-loss drugs, but it has to prove it can use that success to build for the future.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
The proliferation of prediction markets is throttling growth at DraftKings (NASDAQ: DKNG).
Major global investment banks (IBs) have upgraded their forecasts for South Korea's economic growth, citing a strong semiconductor upcycle, a report by the international finance center said Wednesday.
Business is booming, and costs are also increasing.
[SINGAPORE] The following company saw new developments that may affect trading of its securities on Wednesday (Oct 7):
September saw a decline in demat account openings, falling to 2.89 million, which is an 11.5% reduction compared to the previous month.
